31 May 2019: OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Cancer Genome Profiling

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) received approval on June 1, 2019 for insurance coverage for the first time in Japan for the OncoGuide NCC Oncopanel System, a gene mutation analysis set for use in cancer gene profiling (the “System”). The Company received manufacturing and marketing approval for the System on December 25, 2018.

27 May 2019: Sysmex and Osaka University Sign Comprehensive Collaboration Agreement to Foster Innovation in the Healthcare Field

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and Osaka University (Location: Suita, Osaka, Japan; President: Shojiro Nishio) signed a comprehensive collaboration agreement on May 24, 2019 to foster innovation in the healthcare field by leveraging Sysmex’s diagnostic technologies and the knowledge Osaka University possesses in the field of information science. This agreement, […]